<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A"><gtr:id>9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A</gtr:id><gtr:name>Guy's and St Thomas' NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Westminster Bridge Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 7EH</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5007777D-75C9-4C55-9B58-E275FB2ED626"><gtr:id>5007777D-75C9-4C55-9B58-E275FB2ED626</gtr:id><gtr:name>Department of Pharmacology and Clinical Neuroscience</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C96DB0B8-CEAC-4B25-B19B-81F9AF857DFF"><gtr:id>C96DB0B8-CEAC-4B25-B19B-81F9AF857DFF</gtr:id><gtr:name>University of Paris 6</gtr:name><gtr:address><gtr:line1>Bat 121</gtr:line1><gtr:line4>Paris</gtr:line4><gtr:postCode>F-75252</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/49C44558-A75A-448F-9BF7-3F947FA67EB7"><gtr:id>49C44558-A75A-448F-9BF7-3F947FA67EB7</gtr:id><gtr:name>Technical University of Munich</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Randall Div of Cell and Molecular Biophy</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A"><gtr:id>9DB89E2F-30C0-4BB4-8F71-C9E1288FE25A</gtr:id><gtr:name>Guy's and St Thomas' NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Westminster Bridge Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 7EH</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5007777D-75C9-4C55-9B58-E275FB2ED626"><gtr:id>5007777D-75C9-4C55-9B58-E275FB2ED626</gtr:id><gtr:name>Department of Pharmacology and Clinical Neuroscience</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C96DB0B8-CEAC-4B25-B19B-81F9AF857DFF"><gtr:id>C96DB0B8-CEAC-4B25-B19B-81F9AF857DFF</gtr:id><gtr:name>University of Paris 6</gtr:name><gtr:address><gtr:line1>Bat 121</gtr:line1><gtr:line4>Paris</gtr:line4><gtr:postCode>F-75252</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/49C44558-A75A-448F-9BF7-3F947FA67EB7"><gtr:id>49C44558-A75A-448F-9BF7-3F947FA67EB7</gtr:id><gtr:name>Technical University of Munich</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BAA31689-3C17-4D79-8A8C-FCC900A3CD99"><gtr:id>BAA31689-3C17-4D79-8A8C-FCC900A3CD99</gtr:id><gtr:firstName>Mathias</gtr:firstName><gtr:surname>Gautel</gtr:surname><gtr:orcidId>0000-0003-4027-9803</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600251"><gtr:id>A3AF5634-97A6-481B-BC95-D813241386A0</gtr:id><gtr:title>Sarcomeric signallig by giant muscle proteins controlling muscle growth and turnover</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600251</gtr:grantReference><gtr:abstractText>We investigate new mechanisms that control the growth of muscles in response to workload. This will help to understand how muscle loss occurs in patients on intensive care units or with certain genetic muscle diseases. 

Voluntary movement of our body, and the pumping functions of the heart require the actions of striated muscles, so called because of their extremely regular striped pattern when viewed in a microscope. These stripes are repeating patterns of molecular machines, called sarcomeres. The sarcomere is organized by the giant protein titin, the largest protein of the human body. 

Muscle responds rapidly to changes in use, with disuse leading to muscle loss (called atrophy) and exercise leading to muscle growth (called hypertrophy). These events need to be constantly balanced, and require input from sensors for workload. 

We study the role of a protein kinase domain in titin, and the proteins interacting with, in muscle growth and atrophy. We found that the titin kinase can respond to mechanical forces, suggesting it plays a role in the responses of muscle to load. We are studying the mechanism of this mechanosignalling and its disruption in muscle diseases using protein studies and animal models.</gtr:abstractText><gtr:technicalSummary>The giant protein titin is crucially required for assembling the contractile structure of the sarcomeres of striated muscle. It combines mechanical, architectural and signalling functions. We propose to use an integrated approach to study the role of the M-band portion of titin, its protein kinase domain and the proteins interacting with it in signalling and maintenance functions during muscle growth and atrophy. Mutations in titin are also associated with cardiac and skeletal myopathies, and we will study titin signalling in these hereditary diseases, as well as in acquired forms of myopathies like acute quadriplegic myopathy.</gtr:technicalSummary><gtr:fund><gtr:end>2012-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2088529</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical University of Munich</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Biophysics</gtr:department><gtr:description>Biophysics of cytoskeletal proteins</gtr:description><gtr:id>C76D911F-884D-4027-8F27-0A2E073DCAFC</gtr:id><gtr:impact>One joint paper: Pernigo et al., Proc. Natl. Acad. Sci. USA, (2010). 107(7): p. 2908-2913.
Multi-disciplinary collaboration between the physics team in Munich with expertise in optical trap measurements of protein-protein complexes, and our input in muscle protein biochemistry, analysis of sarcomeric protein interactions, and muscle cell biology.</gtr:impact><gtr:partnerContribution>technical and conceptual advances on single-molecule biophysics</gtr:partnerContribution><gtr:piContribution>Concept of research project, generation of recombinant proteins and cell biological validation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Biophysics of mechanosignalling</gtr:description><gtr:id>489767D9-2DF7-4C5F-82C2-18DB661C7137</gtr:id><gtr:impact>Publications 18765796, 18550806</gtr:impact><gtr:partnerContribution>developed new biophysical method for analysis of mechanoenzymatics</gtr:partnerContribution><gtr:piContribution>designed research, provided crucial eagents, wrote paper</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Mechanoenzymatics</gtr:description><gtr:id>52E35523-F41F-446F-8AB8-37001F8BF7A1</gtr:id><gtr:impact>Two 2008 publications (Puchner et al., Proc. Natl. Acad. Sci. USA, (2008). 105(36): p. 13385-13390. Puchner et al., Biophys. J., (2008). 95(1): p. 426-434.), and one recent paper (Stahl et al., Biophys. J., (2011). 101(8): p. 1978-86). Ongoing multi-disciplinary work with the Munich physics team, and our expertise and conceptual background in muscle biochemistry and cell biology.</gtr:impact><gtr:partnerContribution>publications, shared personnel</gtr:partnerContribution><gtr:piContribution>We expanded our research on mechanoenzymatic kinase signalling in collaboration with the Gaub team at the LMU. We identified new target proteins, expressed those and designed new studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Guy's and St Thomas' NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Paediatric Neurology</gtr:department><gtr:description>Congenital autophagy disorders</gtr:description><gtr:id>65845C6E-DA53-45FD-B1BB-A0B9C55F767D</gtr:id><gtr:impact>myotubular myopathy trust award</gtr:impact><gtr:partnerContribution>Identifies patients and candidate disease genes</gtr:partnerContribution><gtr:piContribution>Analyse the impairment of the autophagy/lysosomal pathway and muscle ubiquitin ligases in hereditary paediatric disorders with myopathy/cardiomyopathy.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Pharmacology and Clinical Neuroscience</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Clinical Neurophysiology Unit</gtr:department><gtr:description>Critical illness myopathy</gtr:description><gtr:id>26717C11-22BB-445B-9AAE-B8AE8B828903</gtr:id><gtr:impact>One joint paper:
Ochala et al., J. Physiol., (2011). 589(8): p. 2007-26.
A multi-disciplinary collaboration that combines clinical expertise in critical illness myopathy in Umea with our expertise in muscle mechanosignalling.</gtr:impact><gtr:partnerContribution>We receive samples from a unique rat model of critical illness myopathy to assess changes in mechanosignalling complexes in the pathogenesis of this condition</gtr:partnerContribution><gtr:piContribution>We analyse muscle samples from a unique rat model for critical illness myopathy developed in Umea for biochemical and cellular changes in sarcomeric mechanosignalling complexes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pierre and Marie Curie University - Paris 6</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>UMR 787 (Institute of Myology)</gtr:department><gtr:description>Early-onset Myopathies</gtr:description><gtr:id>61B42B58-C52B-4444-B3A4-7CEF87AA5D72</gtr:id><gtr:impact>Two joint publications:
Carmignac et al., Ann. Neurol., (2007). 61(4): p. 340 - 351.
Fukuzawa et al., J. Cell Sci., (2008). 121(11): p. 1841-1851.
A multi-disciplinary, translational collaboration that elucidates the disease mechanisms of novel early-onset myopathies.</gtr:impact><gtr:partnerContribution>Has provided valuable insight into the human biology of titin kinase and M-band titin by identifying crucial regions affected in early-onset myopathies.</gtr:partnerContribution><gtr:piContribution>We analyse sarcomeric protein mutations leading to early-onset (paediatric) myopathies on the biochemical, biophysical and cell-biological level.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School Visits- Dulwich College, King's College School, James Allen's Girl School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D604B037-012F-4768-89E7-C09DEE340722</gtr:id><gtr:impact>Discussed research topic and biomedical implications with 6th form students

Several pupils mentioned that Cardiovascular research was now a focus of the future study interests. several came for subsequent lab work experience. The schools wish to send more pupils next year.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school visit- Dulwich College</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F1CEA651-261E-40C6-993C-75353B7B40F8</gtr:id><gtr:impact>Discussed research topic and biomedical implications with 6th form students

several students mentioned that Cardiovascular research was now a focus of the future study interests. several came for subsequent lab work experience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>360909</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust project grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>093253/Z/10/Z</gtr:fundingRef><gtr:id>588DACC6-B46F-41AE-AAB5-BE629D74E776</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2101238</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC programme grant 2012-2017</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J010456/1</gtr:fundingRef><gtr:id>637EB128-F4A0-4A73-82A9-C8890FECA66E</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1511810</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Professorship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>CH/08/001</gtr:fundingRef><gtr:id>30354003-4249-4620-9701-99F45737F437</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>536256</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Collaborative Award in Sciences</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>201543/Z/16/Z</gtr:fundingRef><gtr:id>746102F2-F069-4995-B289-10A9D50EE939</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>197860</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>intermediate training network</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Marie Curie Actions</gtr:fundingOrg><gtr:id>9DD00C8D-2CAA-4BC1-9456-CB7209CC0DC4</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>547867</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leducq Transatlantic Network</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Transatlantic Networks of Excellence in Cardiovascular Research Program</gtr:fundingOrg><gtr:fundingRef>11 CVD 04</gtr:fundingRef><gtr:id>A485C82D-53D2-41A5-8FCB-AA34A447ACB0</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>228302</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF project grant 2012-2015</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/11/127/29322</gtr:fundingRef><gtr:id>8838BD42-8F4A-40DA-8AF0-7784597AC546</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>MYBPC3 as a marker of cardiac ischaemia</gtr:description><gtr:id>A73407DB-25A4-4D1F-8434-E24DFC8975FC</gtr:id><gtr:impact>marker still in evaluation
PATENT APPLICATION TERMINATED 2010</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>GB0908071.4</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>MYBPC3 as diagnostic marker</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>MYBPC3 is an early marker of cardiac ischaemia and could offer more sensitive and earlier detection of heart attacks than other established markers.</gtr:description><gtr:id>359F549E-A314-4241-8A7D-DF9D51C7557D</gtr:id><gtr:impact>Ha sled to an optimisation programme for antibodies useful in clinical screening</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>US2012156702</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>US Patent Application &amp;quot;Myocardial Markers&amp;quot;</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contribution to diagnostic guidelines for titinopathies</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>219th ENMC International Workshop Titinopathies International database of titin mutations and phenotypes, Heemskerk, The Netherlands, 29 April-1 May 2016</gtr:guidelineTitle><gtr:id>B22CAD5C-5AB6-4FFC-A962-BD86CC93B643</gtr:id><gtr:impact>Contributions led to establishment of evidence-based criteria how to define pathogenic TTN mutations, which parameters should be included in a titinopathy database, and which clinical parameters should be preferentially monitored in affected patients for best health outcomes and improved diagnosis.</gtr:impact><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Trust Physiological Sciences Funding Committee</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>34DCEDD0-2D89-487B-9957-16A41AA4A146</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Scientific advisor, Association Fran?aise contre les myoathies</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>51214F00-382D-4E9C-9BA5-BC73DC4AEC84</gtr:id><gtr:impact>The committee advises the Association Fran?aise contre les myoathies for the funding of project grants and fellowships in the area of basic muscle research and myopathy research</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>citation in clinical reviews in the neurological area</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3EC0A5B5-AC25-441E-8637-04A11895BDE5</gtr:id><gtr:impact>improved genetic diagnostics of early-onset myopathies</gtr:impact><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>antibodies against Nbr1, MURF2 for immunohistochemistry and Western blotting</gtr:description><gtr:id>12A8B303-677E-4C42-A8A7-718E09C65C1E</gtr:id><gtr:impact>Research Material used for differential diagnosis for Human Myopathy with Early Respiratory Failure</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>reagents and diagnostic criteria for Human Myopathy with Early Respiratory Failure</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>antibodies against titin and obscurin, obscurin-like 1 used in immunohistochemistry and Western blotting of patient material</gtr:description><gtr:id>70415AAE-310C-41AA-B1C7-486133E2D0F6</gtr:id><gtr:impact>Research Material used for differential diagnosis for Human Myopathy with Early Respiratory Failure, Salih Myopathy, tibial muscular dystrophy (TMD) and LGMD2J</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>reagents and diagnostic criteria for Salih Myopathy and LGMD2J</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B7A9DA2-9F49-4541-80FB-567876F9E485"><gtr:id>5B7A9DA2-9F49-4541-80FB-567876F9E485</gtr:id><gtr:title>The Cardiac Stress Response Factor Ms1 Can Bind to DNA and Has a Function in the Nucleus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d67f8631f3149b7544754694e851da3"><gtr:id>4d67f8631f3149b7544754694e851da3</gtr:id><gtr:otherNames>Zaleska M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB81372C-3A75-4D16-B1FC-A21D897E9F5F"><gtr:id>CB81372C-3A75-4D16-B1FC-A21D897E9F5F</gtr:id><gtr:title>Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14b89fa1a299acfb1cb2e5eb468e7110"><gtr:id>14b89fa1a299acfb1cb2e5eb468e7110</gtr:id><gtr:otherNames>Pernigo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2AF28D55-8A67-44A2-829C-07B56D960280"><gtr:id>2AF28D55-8A67-44A2-829C-07B56D960280</gtr:id><gtr:title>MuRF1 activity is present in cardiac mitochondria and regulates reactive oxygen species production in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of bioenergetics and biomembranes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1be75e20e93dc71e4edeb20d46858d2b"><gtr:id>1be75e20e93dc71e4edeb20d46858d2b</gtr:id><gtr:otherNames>Mattox TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0145-479X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3FEC58E-0641-4513-A635-9DF1854F790F"><gtr:id>B3FEC58E-0641-4513-A635-9DF1854F790F</gtr:id><gtr:title>Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f1ae8a0563763e2e20d182af2460349e"><gtr:id>f1ae8a0563763e2e20d182af2460349e</gtr:id><gtr:otherNames>Cullup T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B659407-DF33-41E7-BC0B-7104BD70D16E"><gtr:id>4B659407-DF33-41E7-BC0B-7104BD70D16E</gtr:id><gtr:title>Pathogenic mechanisms in centronuclear myopathies.</gtr:title><gtr:parentPublicationTitle>Frontiers in aging neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8cfe3367645d225c21a352c13d7fb7e7"><gtr:id>8cfe3367645d225c21a352c13d7fb7e7</gtr:id><gtr:otherNames>Jungbluth H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1663-4365</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/70432A72-E21A-4559-B2D9-DA44CC2421FF"><gtr:id>70432A72-E21A-4559-B2D9-DA44CC2421FF</gtr:id><gtr:title>The sarcomeric cytoskeleton: from molecules to motion.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/39b061ea1d9e351b3b409b6c8ff05635"><gtr:id>39b061ea1d9e351b3b409b6c8ff05635</gtr:id><gtr:otherNames>Gautel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-0949</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/07989F7B-D036-4140-90D9-E65BED0E68A9"><gtr:id>07989F7B-D036-4140-90D9-E65BED0E68A9</gtr:id><gtr:title>The crystal structure of the human titin:obscurin complex reveals a conserved yet specific muscle M-band zipper module.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14b89fa1a299acfb1cb2e5eb468e7110"><gtr:id>14b89fa1a299acfb1cb2e5eb468e7110</gtr:id><gtr:otherNames>Pernigo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F7BB8F05-77FE-4849-B6A5-501F38113EDE"><gtr:id>F7BB8F05-77FE-4849-B6A5-501F38113EDE</gtr:id><gtr:title>Structure and interactions of myosin-binding protein C domain C0: cardiac-specific regulation of myosin at its neck?</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6326a76e581e169e899f90642d54251c"><gtr:id>6326a76e581e169e899f90642d54251c</gtr:id><gtr:otherNames>Ratti J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4AD811CE-AEAC-4E36-AEE8-75B3D2EAF3BC"><gtr:id>4AD811CE-AEAC-4E36-AEE8-75B3D2EAF3BC</gtr:id><gtr:title>Myosin binding protein-C activates thin filaments and inhibits thick filaments in heart muscle cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5519fac16f30b0fea0861f5095f77b1"><gtr:id>e5519fac16f30b0fea0861f5095f77b1</gtr:id><gtr:otherNames>Kampourakis T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF09AC72-2DAE-4216-94EE-DF2334A8D749"><gtr:id>DF09AC72-2DAE-4216-94EE-DF2334A8D749</gtr:id><gtr:title>Cytoskeletal protein kinases: titin and its relations in mechanosensing.</gtr:title><gtr:parentPublicationTitle>Pflugers Archiv : European journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/39b061ea1d9e351b3b409b6c8ff05635"><gtr:id>39b061ea1d9e351b3b409b6c8ff05635</gtr:id><gtr:otherNames>Gautel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0031-6768</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D5C12E21-E9A4-4043-830C-25B1BB7CB221"><gtr:id>D5C12E21-E9A4-4043-830C-25B1BB7CB221</gtr:id><gtr:title>EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d17c7bc339ab8d1e53a665e22a4f259"><gtr:id>9d17c7bc339ab8d1e53a665e22a4f259</gtr:id><gtr:otherNames>Byrne S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/59E400AA-A647-444B-8E0D-77B169766E68"><gtr:id>59E400AA-A647-444B-8E0D-77B169766E68</gtr:id><gtr:title>The sarcomeric cytoskeleton: who picks up the strain?</gtr:title><gtr:parentPublicationTitle>Current opinion in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/39b061ea1d9e351b3b409b6c8ff05635"><gtr:id>39b061ea1d9e351b3b409b6c8ff05635</gtr:id><gtr:otherNames>Gautel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0955-0674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2AE2860A-98F2-4857-ADA0-F97C727495E8"><gtr:id>2AE2860A-98F2-4857-ADA0-F97C727495E8</gtr:id><gtr:title>Current and future therapeutic approaches to the congenital myopathies.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8cfe3367645d225c21a352c13d7fb7e7"><gtr:id>8cfe3367645d225c21a352c13d7fb7e7</gtr:id><gtr:otherNames>Jungbluth H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F04349C5-73CB-48A8-BB1B-DE097CB68CCF"><gtr:id>F04349C5-73CB-48A8-BB1B-DE097CB68CCF</gtr:id><gtr:title>Developmental regulation of MURF ubiquitin ligases and autophagy proteins nbr1, p62/SQSTM1 and LC3 during cardiac myofibril assembly and turnover.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1fe8eb2bfe4b5a478a45911c122e1558"><gtr:id>1fe8eb2bfe4b5a478a45911c122e1558</gtr:id><gtr:otherNames>Perera S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B2DB518D-FADD-4BE9-BAC5-2D691DCB1BCC"><gtr:id>B2DB518D-FADD-4BE9-BAC5-2D691DCB1BCC</gtr:id><gtr:title>Mechanoenzymatics of titin kinase.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eaa9151cae989333dcf670bbd92b79c0"><gtr:id>eaa9151cae989333dcf670bbd92b79c0</gtr:id><gtr:otherNames>Puchner EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/843A111D-30E6-4313-B737-16F52A59398C"><gtr:id>843A111D-30E6-4313-B737-16F52A59398C</gtr:id><gtr:title>Legumain and cathepsin-L expression in human unstable carotid plaque.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce0052b4094f5b61b5279a328a990b4b"><gtr:id>ce0052b4094f5b61b5279a328a990b4b</gtr:id><gtr:otherNames>Mattock KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9D0896A5-9692-47FE-9237-174E97A4B9F2"><gtr:id>9D0896A5-9692-47FE-9237-174E97A4B9F2</gtr:id><gtr:title>Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5c8082802ec778386ca3cc5c516bf7e"><gtr:id>f5c8082802ec778386ca3cc5c516bf7e</gtr:id><gtr:otherNames>Rokach O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6F372402-64E7-4FCB-8D50-8F2CB0FFA175"><gtr:id>6F372402-64E7-4FCB-8D50-8F2CB0FFA175</gtr:id><gtr:title>Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band: implications for hereditary myopathies.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/515d6be8779ac138a62eea3bc1a97c17"><gtr:id>515d6be8779ac138a62eea3bc1a97c17</gtr:id><gtr:otherNames>Fukuzawa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09D23B79-D9B3-41AB-8006-5A522262E5A2"><gtr:id>09D23B79-D9B3-41AB-8006-5A522262E5A2</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3258B6D7-4792-478D-82EB-F18ACA042F9A"><gtr:id>3258B6D7-4792-478D-82EB-F18ACA042F9A</gtr:id><gtr:title>Phosphoregulation of the titin-cap protein telethonin in cardiac myocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6a2cc0f14157c7ea0c04fdf092f53a1c"><gtr:id>6a2cc0f14157c7ea0c04fdf092f53a1c</gtr:id><gtr:otherNames>Candasamy AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D6A46FBB-416B-4D21-A794-11E24BF93EA1"><gtr:id>D6A46FBB-416B-4D21-A794-11E24BF93EA1</gtr:id><gtr:title>Dissecting the N-terminal myosin binding site of human cardiac myosin-binding protein C. Structure and myosin binding of domain C2.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b38469ef5b7f2a3e4330a24955ed869b"><gtr:id>b38469ef5b7f2a3e4330a24955ed869b</gtr:id><gtr:otherNames>Ababou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5E0EC694-6E47-40D8-BA16-0CA008F75D74"><gtr:id>5E0EC694-6E47-40D8-BA16-0CA008F75D74</gtr:id><gtr:title>Reply: Aberrant splicing induced by the most common EPG5 mutation in an individual with Vici syndrome.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d17c7bc339ab8d1e53a665e22a4f259"><gtr:id>9d17c7bc339ab8d1e53a665e22a4f259</gtr:id><gtr:otherNames>Byrne S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30A25DED-D097-469F-AF3A-60D415E00916"><gtr:id>30A25DED-D097-469F-AF3A-60D415E00916</gtr:id><gtr:title>Binding of Myomesin to Obscurin-Like-1 at the Muscle M-Band Provides a Strategy for Isoform-Specific Mechanical Protection.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14b89fa1a299acfb1cb2e5eb468e7110"><gtr:id>14b89fa1a299acfb1cb2e5eb468e7110</gtr:id><gtr:otherNames>Pernigo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DFC0EF82-CC54-4995-B822-EC6FE9778A36"><gtr:id>DFC0EF82-CC54-4995-B822-EC6FE9778A36</gtr:id><gtr:title>A conditional gating mechanism assures the integrity of the molecular force-sensor titin kinase.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9a344ed5a561a1cb5adcbce368e7e34f"><gtr:id>9a344ed5a561a1cb5adcbce368e7e34f</gtr:id><gtr:otherNames>Stahl SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/491ABCFA-8D1B-4063-84AA-78872DDFD6DE"><gtr:id>491ABCFA-8D1B-4063-84AA-78872DDFD6DE</gtr:id><gtr:title>C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8cda7f8a9c194d4e9295d55abb1aac89"><gtr:id>8cda7f8a9c194d4e9295d55abb1aac89</gtr:id><gtr:otherNames>Carmignac V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05F818DD-4329-4AD8-AAC5-8938F49DDBF7"><gtr:id>05F818DD-4329-4AD8-AAC5-8938F49DDBF7</gtr:id><gtr:title>The structure and regulation of human muscle a-actinin.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d81004f56ac58dc9576640ab50a5bbd"><gtr:id>3d81004f56ac58dc9576640ab50a5bbd</gtr:id><gtr:otherNames>Ribeiro Ede A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C3280F6C-B123-4ED7-B850-3EEC84EFA4AF"><gtr:id>C3280F6C-B123-4ED7-B850-3EEC84EFA4AF</gtr:id><gtr:title>Developmental regulation of MURF E3 ubiquitin ligases in skeletal muscle.</gtr:title><gtr:parentPublicationTitle>Journal of muscle research and cell motility</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1fe8eb2bfe4b5a478a45911c122e1558"><gtr:id>1fe8eb2bfe4b5a478a45911c122e1558</gtr:id><gtr:otherNames>Perera S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0142-4319</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B5305934-D284-4EA0-A465-68108DAA0B28"><gtr:id>B5305934-D284-4EA0-A465-68108DAA0B28</gtr:id><gtr:title>Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f547069043eae9bb10085e941d5c88e"><gtr:id>9f547069043eae9bb10085e941d5c88e</gtr:id><gtr:otherNames>Braun T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/76C26EC8-0E76-4951-BA9A-3B749B654873"><gtr:id>76C26EC8-0E76-4951-BA9A-3B749B654873</gtr:id><gtr:title>Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7bb97d3432e190128782926f4b1922b9"><gtr:id>7bb97d3432e190128782926f4b1922b9</gtr:id><gtr:otherNames>Ochala J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5CDD5E9F-22C5-4A70-893B-19A52C4F54DB"><gtr:id>5CDD5E9F-22C5-4A70-893B-19A52C4F54DB</gtr:id><gtr:title>Interactions with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6fae2c0b433fc03bdc58240e7db74bc6"><gtr:id>6fae2c0b433fc03bdc58240e7db74bc6</gtr:id><gtr:otherNames>Waters S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E2BEFD07-614A-4EEB-A908-881BE732F9F3"><gtr:id>E2BEFD07-614A-4EEB-A908-881BE732F9F3</gtr:id><gtr:title>Comparing proteins by their unfolding pattern.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eaa9151cae989333dcf670bbd92b79c0"><gtr:id>eaa9151cae989333dcf670bbd92b79c0</gtr:id><gtr:otherNames>Puchner EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2826FBD3-EFDC-48F1-8C97-D325DA368AC2"><gtr:id>2826FBD3-EFDC-48F1-8C97-D325DA368AC2</gtr:id><gtr:title>Rigid conformation of an immunoglobulin domain tandem repeat in the A-band of the elastic muscle protein titin.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66607893a8aa856442e5814ad0f2c098"><gtr:id>66607893a8aa856442e5814ad0f2c098</gtr:id><gtr:otherNames>M?ller S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30D95F94-E673-468F-B389-1897D1FFC185"><gtr:id>30D95F94-E673-468F-B389-1897D1FFC185</gtr:id><gtr:title>Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/84e22cb32a9742afbbcd9d122ace0a4d"><gtr:id>84e22cb32a9742afbbcd9d122ace0a4d</gtr:id><gtr:otherNames>Bardswell SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/14438908-7BAB-4520-806F-F48AA96CAC3B"><gtr:id>14438908-7BAB-4520-806F-F48AA96CAC3B</gtr:id><gtr:title>Recessive TTN truncating mutations define novel forms of core myopathy with heart disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d278d82b034d5730cab1b5d588400d77"><gtr:id>d278d82b034d5730cab1b5d588400d77</gtr:id><gtr:otherNames>Chauveau C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2632B944-0A77-4469-9D56-4A5EB1777945"><gtr:id>2632B944-0A77-4469-9D56-4A5EB1777945</gtr:id><gtr:title>The sarcomere and sarcomerogenesis.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a65ab053b2d080800376f316ea62593"><gtr:id>3a65ab053b2d080800376f316ea62593</gtr:id><gtr:otherNames>Ehler E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2EFF000A-2FCD-47F0-B32B-F1D32C5594B2"><gtr:id>2EFF000A-2FCD-47F0-B32B-F1D32C5594B2</gtr:id><gtr:title>The sarcomere and the nucleus: functional links to hypertrophy, atrophy and sarcopenia.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/39b061ea1d9e351b3b409b6c8ff05635"><gtr:id>39b061ea1d9e351b3b409b6c8ff05635</gtr:id><gtr:otherNames>Gautel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3AAD1294-DAA9-4560-BC8A-4DBA087FA904"><gtr:id>3AAD1294-DAA9-4560-BC8A-4DBA087FA904</gtr:id><gtr:title>Myosin binding protein C positioned to play a key role in regulation of muscle contraction: structure and interactions of domain C1.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b38469ef5b7f2a3e4330a24955ed869b"><gtr:id>b38469ef5b7f2a3e4330a24955ed869b</gtr:id><gtr:otherNames>Ababou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600251</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>